To exclude the possibility of a distinct subset of KL ADC that may express p63, we further validated SqCC or ADC subtypes in KL tumours by double-staining with two SqCC markers, p63 and CK5, as well as a combination of SqCC and ADC markers, CK5 and TTF-1. The gene discussed is KRT5; the disease is neoplasm.